NCT06567652View on ClinicalTrials.gov

Safety and Efficacy of Persistent Atrial Fibrillation Ablation With a Cryoballoon Technology

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

August 31, 2022

Study Completion Date

September 1, 2022

Conditions
Atrial Fibrillation
Interventions
DEVICE

catheter ablation

All patients underwent pulmonary vein isolation (and eventually left atrial posterior wall isolation) with the POLARx™ cryoballoon system

Trial Locations (1)

1090

UZ Brussel Heart Rhythm Management Center, Brussels

All Listed Sponsors
lead

Universitair Ziekenhuis Brussel

OTHER

NCT06567652 - Safety and Efficacy of Persistent Atrial Fibrillation Ablation With a Cryoballoon Technology | Biotech Hunter | Biotech Hunter